 10
BioFocus plc
Remuneration Report
for the year ended 31 December 2002
The Board has established a Remuneration Committee which has overall responsibility for remuneration policy and specific responsibility for
determining the remuneration of the executive directors.  The members of the Remuneration Committee are Norman Burden, the Non-
Executive Chairman of the company who also acts as Chairman of the Committee, and Brian Adger, a non-executive director.  The
Remuneration Committee has access to professional advice from inside and outside the group.
Policy on remuneration of executive directors
The remuneration policy in respect of executive directors is to ensure that individual remuneration reflects the performance of the group, the
performance of each director and the interests of shareholders and that the overall remuneration package enables the group to attract and
retain high calibre executives.  The remuneration package of executive directors presently consists of basic salary or consultancy fees, medical
insurance, life assurance, company pension contributions and long term incentive schemes.
Service and consultancy agreements
The company entered into a service agreement with David Stone on 27 January 1997.  The agreement may be terminated by either party
giving 12 months' notice.
On 27 January 1997 the company entered into consultancy agreements with the following directors.  The agreements may be terminated by
either party giving 12 months' notice:
Director Position Annual number of days
Stephen France Finance Director 200
Keith Moscrop Business Development Director 188
Mr Moscrop resigned from the Board on his retirement on 31 December 2002. With effect from 1 January 2003, Mr France works for the
group on a full time basis.
Non-executive directors
The remuneration of the non-executive directors is determined by the Board of Directors.
On  25 November 1998 the company appointed Norman Burden as Non-Executive Chairman.  Mr Burden's appointment may be terminated
by either party on 12 months' written notice.
On 1 November 1999 the company appointed Brian Adger as a non-executive director.  Dr Adger's appointment may be terminated by either
party on 3 months' written notice.
On 11 June 2001 the company appointed Ian Kent as a non-executive director.  Mr Kent's appointment may be terminated by either party on
3 months' written notice.
Mark Treherne was appointed as Commercial Director on 11 June 2001.  On 1 March 2002 Dr Treherne became a non-executive director.
His appointment as non-executive director may be terminated at any time by either party on 3 months' written notice. 11
BioFocus plc
Remuneration Report
for the year ended 31 December 2002 continued
Directors' remuneration
The following tables show the detailed analysis of directors' remuneration:
2002: Compensation Total
for loss of Estimated excluding
Consultancy executive benefits pension Pension
Salary fees office Fees in kind contributions contributions
 000  000  000  000  000  000  000
Norman Burden       31   31  
David Stone 121     121 6
Geoffrey McMillan 28     28 1
Stephen France   88     1 89 4
Keith Moscrop   49     1 50 3
Brian Adger       15   15  
Ian Kent       15   15  
Mark Treherne 15   50 10   75  
164 137 50 71 2 424 14
2001: Total
Estimated excluding
Consultancy benefits pension Pension
Salary fees Fees in kind contributions contributions
 000  000  000  000  000  000
Norman Burden     26   26  
David Stone 107    107 5
Paul Doyle 35    35 2
John Harris 35    35 2
Valerie Rose 34    34 2
Alan Clabon 28    28 1
Stephen France   63    63 
Keith Moscrop   75   1 76  
Brian Adger     12   12  
Ian Kent     8   8  
Mark Treherne 49    49 5
288 138 46 1 473 17
Long term incentive schemes
The company established an approved Share Option Scheme in 1998.  Unapproved and EMI Option Schemes were established in 2000.  The
grant of options under these schemes is at the discretion of the Remuneration Committee.  Details of options granted to the directors under
the approved share option scheme are shown in the directors' report.
Norman Burden
Chairman of the Remuneration Committee
4 March 2003